U.S. stocks open lower, weight loss drug concept stocks generally rise, Novo Nordisk up over 5%

Glonghui, February 9th｜At the opening of the US stock market, the Dow Jones fell 0.14%, the S&P 500 Index dropped 0.24%, and the Nasdaq declined 0.34%. Weight-loss drug concept stocks generally rose, with Novo Nordisk up over 5% and Eli Lilly up over 2%, while Hims & Hers, which is facing lawsuits over generic semaglutide, plunged 22%. Storage concept stocks weakened, with Micron Technology falling over 3%. Google A dropped 0.58%; its parent company Alphabet plans to raise about $15 billions through a US dollar bond issuance. Oracle rose 4.2% after Davidson Investment Bank upgraded its stock rating from "Neutral" to "Buy." QuantumScape surged 12.5% after launching pilot production of solid-state batteries last week. STMicroelectronics rose 7.6% after reaching a multi-billion dollar cooperation agreement with Amazon Web Services.